Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP519018.RAyA0PYUxHk1_49mVmoFcEFRfjDoCPDn3pMIqZwWbC1pU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP519018.RAyA0PYUxHk1_49mVmoFcEFRfjDoCPDn3pMIqZwWbC1pU130_assertion type Assertion NP519018.RAyA0PYUxHk1_49mVmoFcEFRfjDoCPDn3pMIqZwWbC1pU130_head.
- NP519018.RAyA0PYUxHk1_49mVmoFcEFRfjDoCPDn3pMIqZwWbC1pU130_assertion description "[Oral administration of penta-O-galloyl-?-D-glucose suppresses triple-negative breast cancer xenograft growth and metastasis in strong association with JAK1-STAT3 inhibition.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP519018.RAyA0PYUxHk1_49mVmoFcEFRfjDoCPDn3pMIqZwWbC1pU130_provenance.
- NP519018.RAyA0PYUxHk1_49mVmoFcEFRfjDoCPDn3pMIqZwWbC1pU130_assertion evidence source_evidence_literature NP519018.RAyA0PYUxHk1_49mVmoFcEFRfjDoCPDn3pMIqZwWbC1pU130_provenance.
- NP519018.RAyA0PYUxHk1_49mVmoFcEFRfjDoCPDn3pMIqZwWbC1pU130_assertion SIO_000772 21289371 NP519018.RAyA0PYUxHk1_49mVmoFcEFRfjDoCPDn3pMIqZwWbC1pU130_provenance.
- NP519018.RAyA0PYUxHk1_49mVmoFcEFRfjDoCPDn3pMIqZwWbC1pU130_assertion wasDerivedFrom befree-20150227 NP519018.RAyA0PYUxHk1_49mVmoFcEFRfjDoCPDn3pMIqZwWbC1pU130_provenance.
- NP519018.RAyA0PYUxHk1_49mVmoFcEFRfjDoCPDn3pMIqZwWbC1pU130_assertion wasGeneratedBy ECO_0000203 NP519018.RAyA0PYUxHk1_49mVmoFcEFRfjDoCPDn3pMIqZwWbC1pU130_provenance.